baber/WOPTO huggingface dataset:
Patent CA-2499294-A1 (CA)
Title: Optical accelerator and generalized optical vortices
Inventor: CURTIS JENNIFER E
IPC: G21K1/00
Filed: 2003-09-11
Abstract: A method and system for generating modulated optical vortices. Optical vortices can be used for a variety of applications, such as applying controlled torque or controlled force patterns to objects from a few nanometers to hundreds of micrometers in size. Numerous optical modes of optical vortices can be created to meet virtually any desired need in manipulating of objects. Furthermore, one can modify the wavefront of a beam of light in a specific way to create a new type of optical trap useful for manipulating mesoscopic materials. When the modified beam is brought to a focus, the resulting optical trap exerts forces transverse to the optical axis that can be used to transport mesoscopic matter such as nanoclusters, colloidal particles, and biological cells.
Patent CA-2500089-A1 (CA)
Title: Thread for vascular stent and vascular stent using the thread
Inventor: IGAKI KEIJI
IPC: A61M29/02
Filed: 2003-09-25
Abstract: A thread (1) for constructing a vascular stent which is to be introduced int o a vessel and retained therein. This thread is formed by melt-spinning a biodegradable polymer and a drug-containing layer (2) made of the same biodegradable polymer as the biodegradable polymer constituting the thread i s formed on the surface of the thread.
Patent CA-2500822-A1 (CA)
Inventor: BOECKH ALBERT
IPC: A01N43/90
Filed: 2003-09-29
Abstract: This invention provides for, inter alia, spot-on compositions for the treatment or prophylaxis of parasite infestations in mammals or birds which comprise: (1) at least one nodulisporic acid derivative; (2) an acceptable liquid carrier vehicle; and (3) optionally, a crystallization inhibitor. The invention also provides for a method of treating parasitic infestations or for the prophylaxis of parasite infestations in mammals or birds which comprise topically applying to said mammal or bird an effective amount of a composition according to the present invention. Further, this invention relates to an amidation process to prepare amide derivatives of nodulisporic acid and to intermediate formed in this process.
Patent CA-2500858-A1 (CA)
Title: Method and system for cryoablating fibroadenomas
Inventor: FOY GLENN
IPC: A61B19/00
Filed: 2003-10-06
Abstract: A cryosurgical system adapted for treatment of fibroadenomas (4) within the breast of a patient. The system includes cryoprobes (6) and a control system which operates the cryoprobes to accomplish freezing in two stages, including a high power freeze and a low power freeze.
Patent CA-2502837-A1 (CA)
Inventor: UCKUN FATIH M
IPC: A61K31/675
Filed: 2003-10-24
Abstract: La présente invention concerne des procédés pour inhiber la réplication virale dans une cellule infectée avec un brin résistant du VIH, les procédés comprenant l'administration à la cellule infectée d'une quantité de dérivé aryl phosphate de d4T, capable d'inhiber la réplication virale.
Patent CA-2502934-A1 (CA)
Title: Assembly of insulating glass structures on a integrated sash
Inventor: HORNUNG ROBERT E
IPC: E06B3/673
Filed: 2003-10-07
Abstract: A sash frame is provided having a first mounting surface for a first glazing pane and a second mounting surface for mounting a second glazing pane substantially parallel to the first glazing pane. The first and second mounting surfaces are spaced apart to provide an insulating space between th e glazing panes. An evacuation opening is provided in communication with the insulating space. The first glazing pane is adhesively mounted to the first mounting surface and the second glazing pane is adhesively mounted to the second mounting surface. Air is allowed to exhaust through the evacuation opening as the insulating space is formed between the glazing panes. A vacuu m is drawn from the evacuation opening to draw the first and second glazing panes closer together after the panes have been mounted on their respective mounting surfaces. Mounting of the glazing panes may also be facilitated usi ng a roll press.
Patent CA-2508309-A1 (CA)
Inventor: SAGAWA HIROAKI
IPC: A61P19/10
Filed: 2003-12-05
Abstract: L'invention concerne un remède ou un moyen pour prévenir des maladies qui engendrent la nécessité de renforcer la production de protéines ostéogéniques ou de favoriser l'ostéogenèse, caractérisé en ce qu'il comprend, en tant qu'ingrédient actif, au moins un composé sélectionné dans le groupe rassemblant (a) des saccharides acides, (b) de l'acide polyacrylique, (c) de l'acide chlorogénique et (d) de l'acide chlorogénique oxydé, ou un extrait d'origine algale ; un activateur de production de protéines ostéogéniques ou un promoteur d'ostéogenèse ; et un aliment, une boisson ou de la nourriture servant à renforcer la production de protéines ostéogéniques ou favoriser l'ostéogenèse.
Patent CA-2518465-A1 (CA)
Title: Dipeptidyl peptidase inhibitors
Inventor: ZHANG ZHIYUAN
IPC: C07D285/16
Filed: 2004-03-24
Abstract: Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV  and other S9 proteases that comprise a compound comprising the formula (I):  wherein Q is selected from the group consisting of CO, SO, SO2, or C=NR9; and R1, R2, R3 and R4 are as defined herein.
Patent CA-2522344-A1 (CA)
Inventor: SIBLEY CHRISTOPHER
IPC: G09F9/30
Filed: 2005-10-07
Abstract: An electronic sign includes a support structure having at least one display mounting surface. A display film of light emitting material containing a matrix of pixels is mounted on each display mounting surface of the support structure. An interface is provided which is adapted for downloading a message to be displayed on the display film.
Patent CA-2522645-A1 (CA)
Inventor: LUNDGREN-AEKERLUND EVY
IPC: C12N5/0735
Filed: 2004-04-14
Abstract: The present invention provides a monoclonal antibody or a fragment thereof binding to the extracellular I-domain of integrin alpha10beta1 and a hybridoma cell line deposited at the Deutsche Sammlung von Microorganismen und Zellkulturen GmbH under the accession number DSM ACC2583. Furthermore, the present invention also provides a monoclonal antibody or a fragment thereof binding to the extracellular I-domain of integrin alpha10beta1 produced by the hybridoma cell line deposited. Methods and uses of said antibody or a fragment thereof in identifying and selecting cells of a chondrogenic nature for treatment purposes, in particular for the identification and isolation of chondrocytes, mesenchymal progenitor cells and embryonic stem cells for tissue engineering of cartilage, or for identifying diagnostic and therapeutic tools in studying the biological role and the structural/functional relationships of the integrin alpha10beta1 with its various extracellular matrix ligands are also included.
Patent CA-2523225-A1 (CA)
Title: Method of treating digested sludge
Inventor: RECKTENWALD MICHAEL
IPC: C02F11/14
Filed: 2004-04-22
Abstract: A method of treating, in wastewater purification, sludge containing organic matter, divalent iron and phosphorus, in which the sludge is treated at 0-100%C with an acid at a pH of 1-5 for dissolution of divalent iron and phosphorus from the sludge, the sludge is supplied with an oxidiser selected from hydrogen peroxide and percompounds, divalent iron being oxidised by Fenton~s reaction to trivalent iron, and (i) trivalent iron being precipitated as trivalent iron phosphate, (ii) free radicals with a deodorisation and sanitation effect being formed by Fenton~s reaction, the sludge then being dewatered at a pH of at most 7, and the aqueous solution obtained in dewatering being recirculated to the wastewater purification. The method is characterised in that the sludge that is treated is made to contain dissolved iron and phosphorus at a molar ratio Fe:P of above 1:1.
Patent CA-2524145-A1 (CA)
Inventor: PANJABI MANOHAR M
IPC: A61B17/70
Filed: 2004-04-30
Abstract: A dynamic spine stabilizer moves under the control of spinal motion providing increased mechanical support within a central zone corresponding substantially to the neutral zone of the injured spine. The dynamic spine stabilizer includes a support assembly and a resistance assembly associated with the support assembly. The resistance assembly generates greater increase in mechanical force during movement within the central zone and lesser increase in mechanical force during movement beyond the central zone. A method for using the stabilizer is also disclosed.
Patent CA-2524447-A1 (CA)
Inventor: MACLEAN BRADLEY R
IPC: A47G27/02
Filed: 2005-10-24
Abstract: A liquid-controlling mat, comprising a formation comprising a plurality of individual cells for containing liquid, each of said cells having a cell wall; a plurality of distribution channels, one connecting each cell to each adjacent cell, each distribution channel being positioned on the internal cell wall at a height so as to channel liquid to the adjacent cell when a cell liquid level exceeds a predetermined limit; a perimeter wall for preventing liquid from leaking to an area outside the wall.
Patent CA-2525792-A1 (CA)
Title: Matrices elastomeres reticulees, leur production et leur utilisation dans des dispositifs implantables
Inventor: SENDIJAREVIC AISA
IPC: A61F2/28
Filed: 2004-05-17
Abstract: L'invention concerne des matrices élastomères réticulées biodurables qui sont élastiquement compressibles, leur production et leurs utilisations, y compris leurs utilisations dans des dispositifs implantables chez des patients ou pour le traitement topique de patients, êtres humains ou animaux, aux fins de traitement, de nutrition ou à d'autres fins utiles.
Patent CA-2528307-A1 (CA)
Inventor: HAN DAESOO
IPC: G21K3/00
Filed: 2004-06-02
Abstract: A narrow band x-ray filter can include: a substrate; and a sheaf of one or more reflection units stacked upon each other on the substrate. Each reflection unit can include: a first set of at least two discrete spacers on a respective underlying structures, a reflector disposed on the first set of spacers so as to form a void between the respective underlying structure and the reflector; and a first set of at least two discrete shims disposed on the first set of at least two spacers, each shim being at least substantially the same thickness as the reflector. A first device to produce a narrow band x-ray beam may include such a filter or an x-ray telescope. A second device to make an x-ray image of a subject may include the first device.
Patent CA-2529854-A1 (CA)
Title: Methods for inhibiting or reversing tau filament fibrillization
Inventor: KHATAMI SAM
IPC: A61K31/428
Filed: 2004-06-21
Abstract: Methods for inhibiting and/or reversing tau filament formation or fibrillization are provided. These methods can be used for treating certain neurological disorders in vivo by administering pharmaceutical compositions which inhibit and/or reverse tau filament formation or fibrillization. A  preferred composition comprises 3-(2-hydroxyethyl)-2-[2-[[3-(2-hydroxyethyl)-5-methoxy-2-benzothiazolylidene]methyl]-1-butenyl]-5-methoxybenzothiazolium.
Patent CA-2530934-A1 (CA)
Title: Aluminum/zirconium/glycine antiperspirant actives stabilized with betaine
Inventor: CAI HENG
IPC: C07F7/00
Filed: 2004-06-24
Abstract: A stabilized aluminum/zirconium/glycine salt comprising a Betaine of Formula I  as additive: in a sufficient amount to have (a) an overall (Betaine +  glycine)/ Zr ratio in the range of 0.1-3.0:1, (b) a ratio of Betaine to glycine of at least 0.001:1; and (c) sufficient Betaine so that at least 0.1%  of the ratio of Betaine + glycine is contributed by Betaine.
Patent CA-2531079-A1 (CA)
Title: A process and catalyst for the selective hydrogenation of diolefins contained in an olefin containing stream and for the removal of arsenic therefrom and a method of making such catalyst
Inventor: HIMELFARB PAUL BENJERMAN
IPC: C07C7/163
Filed: 2004-06-15
Abstract: A catalyst having dual functionality for the removal of arsenic and the selective hydrogenation of diolefins from monoolefin-containing hydrocarbon streams that have an arsenic concentration and a diolefin concentration, and processes for making and using such catalyst. The catalyst is a heat treated shaped mixture of a refractory oxide and a Group VIII metal that is overlaid with additional Group VIII metal.
Patent CA-2532071-A1 (CA)
Title: Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands
Inventor: COLE DEREK CECIL
IPC: A61K31/55
Filed: 2004-07-19
Abstract: The present invention provides a compound of formula (I) and the use thereof in the therapeutic treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
Patent CA-2532313-A1 (CA)
Title: Medicament for treatment of dermal pigmentation
Inventor: ITAI AKIKO
IPC: A61P17/00
Filed: 2004-07-16
Abstract: Preventive and/or therapeutic drugs for chromatosis and/or skin cancer, containing as the active ingredient substances selected from the group consisting of compounds represented by the general formula (I), pharmacologically acceptable salts of the same, and hydrates and solvates thereof: (I) wherein X is a connecting group whose main chain has 2 to 5 atoms (which group may be substituted); A is hydrogen or acetyl; E is optionally substituted aryl or optionally substituted heteroaryl; and Z is arene which may have a substituent in addition to the groups represented by the general formulae: -O-A (wherein A is as defined above) and -X-E (wherein X and E are each as defined above) or heteroarene which may have a substituent in addition to the groups represented by the general formulae: -O-A (wherein A is as defined above) and -X-E (wherein X and E are each as defined above).
Patent CA-2534320-A1 (CA)
Title: Ultrasonic imaging catheter
Inventor: COUVILLON LUCIEN ALFRED JR
IPC: G01S15/89
Filed: 2004-07-29
Abstract: An ultrasonic imaging catheter apparatus and a method of using the same to scan the inner wall of a body lumen. The ultrasonic imaging catheter apparatus comprises: (a) a flexible elongate element adapted for insertion into a body lumen, the elongate element having distal and proximal ends; (b) an ultrasonic transducer generating and detecting ultrasonic energy disposed proximate the distal end of the elongate element; (c) a reflective member disposed proximate the ultrasonic transducer and optionally rotatable with respect to an axis of the body lumen, wherein the reflective member is adapted to reflect (i) ultrasonic energy generated by the ultrasonic transducer to a wall of the body lumen and (ii) ultrasonic energy reflected by the wall back to the transducer;  and (d) an actuator (140), for example, an electroactive polymer actuator, adapted to change the angle of incidence of the ultrasonic energy relative to the reflective member.
Patent CA-2534590-A1 (CA)
Inventor: ABOUAF MARC
IPC: H01M/
Filed: 2004-06-09
Abstract: The disclosure is directed to a solid oxide fuel cell stack. The solid oxide fuel cell stack includes at least two solid oxide fuel cells. The two solid oxide fuel cells share a common electrode.
Patent CA-2536729-A1 (CA)
Title: Journal bearing backing ring
Inventor: REED MARTIN EARL
IPC: F16C33/76
Filed: 2006-02-16
Abstract: A bearing assembly is provided having a roller bearing with an inner case fitted around the journal portion of an axle. An outer raceway combines with the inner raceway to receive roller elements. A backing ring is centered to the shaft fillet. An annular wear ring is positioned between the inner case and the backing ring. An annular sealant bead or a sealant ring form a seal between the shaft shoulder and the backing ring.
Patent CA-2537050-A1 (CA)
Inventor: BENNETT PAUL JAMES LESLIE
IPC: A61M16/20
Filed: 2004-09-03
Abstract: A gas-powered resuscitator is operable either in a manual mode or an automatic mode. The resuscitator includes an oscillatory timing valve (14) having an outlet (23) connected to a bi-stable valve (25), the operation of which is piloted by a manual valve (16). The outlet (26) of the bi-stable valve (25) connects to the outlet (2) of the resuscitator via a rotatable control (32) and a patient valve (41). The outlet (26) of the bi-stable valve (25) also connects to the control inlet (34) of the timing valve (14). The manual valve (16) has a button (62) that can be pushed down manually in the manual mode or can be held down in the automatic mode by rotating a locking ring (262). The maximum duration of cycles is limited by operation of the timing valve (14), whether the resuscitator is operated manually or automatically.
Patent CA-2545115-A1 (CA)
Inventor: THURSTON LISA
IPC: G01N33/68
Filed: 2004-11-08
Abstract: The present invention provides a method for determining the suitability of a sample of mammalian semen for cooling and/or cryopreservation or storage, which comprises: (a) providing said sample of semen; (b) determining the level of a hydrophobic stimulator of 11.beta.-HSD activity in said sample; and (c) assessing, from the level of 11.beta.-HSD stimulator determined, the suitability of the semen sample for cooling and/or cryopreservation or storage. The present invention also provides a method of obtaining a hydrophobic product that improves the tolerance of mammalian semen to cooling and/or cryopreservation or storage, a method of improving the survival rate of sperm intended for cooling and/or cryopreservation or storage and a method of performing an assisted conception/reproductive procedure comprising contacting an oocyte with sperm obtained by a method according to the present invention.
Patent CA-2547064-A1 (CA)
Inventor: VAN OTTERLO WILLEM
IPC: A61K31/4412
Filed: 2004-12-15
Abstract: There is provided a compound of formula (I) wherein R1, R2a, R2b, R3a, R3b, R4, R5, R6, A, G and L have meanings given in the description, which compounds are useful as, or are useful as prodrugs of, competetive inhibitors of trypsin-like proteases, such as trombin, and thus, in particular, in the treatment of conditions where inhibition of thrombin is beneficial (e,g. conditions, such as thrombo-embolisms, where inhibition of trombin is required or desired, and/or conditions wherea anticoagulant thererapy is indicated).
Patent CA-2552529-A1 (CA)
Inventor: PERKOWSKI DAVID A
IPC: C07H3/02
Filed: 2005-01-14
Abstract: D-Ribose is administered before and after general anaesthesia to reduce the time to recover from the effects of general anaesthesia. Preferably, pyrogen-free D-Ribose is administered intravenously during general anaesthesia and the interval post-anaesthesia before oral administration can be resumed. D-Glucose may be co-administered to reduce the effect of hypoglycemia that may be seen with D-Ribose administration.
Patent CA-2553376-A1 (CA)
Title: Method of deuteration using mixed catalyst
Inventor: SAJIKI HIRONAO
IPC: C07C51/353
Filed: 2004-12-21
Abstract: A method of deuteration in which a compound with aromatic ring and/or heterocycle having an enhanced deuteration ratio can be obtained. There is provided a method of deuterating a compound with aromatic ring and/or heterocycle, characterized in that a compound with aromatic ring and/or heterocycle is reacted with a deuterium source in the presence of an activated mixed catalyst composed of at least two members selected from among a palladium catalyst, a platinum catalyst, a rhodium catalyst, an iridium catalyst, a ruthenium catalyst, a nickel catalyst and a cobalt catalyst.
Patent CA-2553618-A1 (CA)
Inventor: PENG HAIQING
IPC: C01B31/02
Filed: 2005-01-18
Abstract: The present invention is directed toward compositions comprising carbon nanotubes (CNTs) that are sidewall-functionalized with amino acid groups, and to amino acid compositions comprising carbon nanotubes. The present invention is also directed to simple and relatively inexpensive methods for the preparation of such compositions. Such compositions are expected to greatly extend the bio-medical applications of CNTs.
Patent CA-2554279-A1 (CA)
Inventor: SWAYZE JEFFREY S
IPC: A61F2/82
Filed: 2006-07-27
Abstract: Various methods and devices for dilating strictures in a lumen are provided.  In an exemplary embodiment, a stricture dilation device is provided having an elongate shaft with at least one electrically expandable actuator coupled thereto and adapted to radially expand to dilate a stricture in a lumen.
Patent CA-2554540-A1 (CA)
Inventor: TSIRTSIS GEORGE
IPC: H04L29/06
Filed: 2004-01-26
Abstract: Methods and apparatus for supporting network layer protocol version independent mobility management are described. In accordance with the present invention, the signaling method used to set-up the redirection (encapsulation or tunnel) is separated from the type of redirection being set-up. Through the use of a Protocol Independent Mobility Management Protocol and/or modules for implementing one or more aspects of the Protocol of the present Invention, Mobile IPv4 and IPv6 may run an top of any version of the network layer and can set-up tunnels of any network layer version over any other network layer version. Various features of the invention are used to establish tunnels which are capable of being used to commutate IPv4 and/or IPv6 packets (520, 530).  Other features are directed to storing and using state information which allows IPv4 and/or IPv6 packets (520, 530) to be sent through a tunnel established using IPv4 or IPv6 type signaling (512).
Patent CA-2556037-A1 (CA)
Title: Fasteners, especially temporary fasteners
Inventor: BLATTMANN LEE DAVID
IPC: F16L3/233
Filed: 2005-02-04
Abstract: Fastener (80) joins together work pieces (14, 18) and has longitudinal body (82) with first work engaging member (86) mounted on it. Second work engagin g member (90) is associated with longitudinal body (82) and may be integral wi th il, or joined to it or mounted on it. Ratchet teeth (22) and ratchet lock (9 2) allow for adjustment of the position of first work engaging member (86) on longitudinal body (82). Second work engaging member (90) includes leaf membe rs (94) capable of assuming a first position of narrow cross-sectional area (as shown in the drawing), and a second position of a wide cross-sectional area under the influence of expanded part (100). Fastener (80) may be removable from work pieces (14, 18).
Patent CA-2556281-A1 (CA)
Title: Network and methods for integrating individualized clinical test results and nutritional treatment
Inventor: KANE EDWARD
IPC: G16H20/60
Filed: 2005-02-16
Abstract: The present invention provides networks and method for linking consumers and nutritional pharmacologists offering personalized nutritional information through a central network site. The network includes a central integration site through which network members communicate with each other. The central integration site stores two or more databases in the storage medium. The databases store biochemical marker data information, nutritional and/or drug data information including a record for association and effect of nutrients with a particular biochemical marker, and/or drug. The network of the invention provides individualized nutritional diagnostic and treatment to consumers on the basis of their clinical test results.
Patent CA-2556772-A1 (CA)
Title: Reagent delivery system, dispensing device and container for a biological staining apparatus
Inventor: FAVUZZI JOHN A
IPC: G01N1/31
Filed: 2005-02-28
Abstract: The invention concerns reagent delivery system for an apparatus for processing of biological samples arranged on microscope slides, comprising a reagent section having one or more reagent containers; a slide section in which at least one microscope slide is arranged; a probe for dispensing a portion of reagent onto a predetermined microscope slide, and means for handling the probe. The probe comprises a continuous prove tubing element extending through a rigid probe member and connecting the probe tip to a pneumatic pressure regulation device. The reagent containers are adapted for cooperation with the probe tip. In this manner a high though-put and a very low carry over of fluid tresidues is achieved since there is no assembled parts making up the inside volume of the probe in which the fluid may be retained.